We would like to know if you are interested in supporting a Melbourne Medicinal Cannabis Forum for the manufacture of medicinal cannabis before a Symposium to educate doctors and nurses, the Medicinal Cannabis Symposium is run by UIC Australian Medicinal Cannabis on the 23, 24, 25 June 2017 in Melbourne, Victoria. Speaking with Lucy Haslam,…
On October 31, the ODC released an online smart form and “flat” paper forms to apply for a cultivation, production or research medicinal cannabis licence. This online form can also be used if you seek a manufacturing licence but ONLY if you are also applying for a cultivation and/or production licence or a research licence….
Today the TGA just released a new medicinal cannabis GMP compliance guide titled “Guidance on GMP compliance for the manufacture of medicinal cannabis for supply under ‘approved access’ provisions“. Not sure there would be any experienced GMP consultant surprised by any of the updates, as expected the TGA continues to follow convention wisdom, a medicine is…
The recent scheduling changes to medicinal cannabis, which includes cannabidiol (abbreviated as “CBD”) and tetrahydrocannabinols (“THC”), moving it from Schedule 9 (prohibited substance) to Schedule 8 (controlled substance). This change, coupled with the rapidly evolving legislative changes around both cultivation and patient access to medicinal cannabis, have many Australian cultivator and manufacturing innovators on high…
For anyone watching the legislative changes around medicinal cannabis which includes Cannabidiol (CBD) and tetrahydrocannabinols (THC) in Australia the announcement yesterday (August 31st) that changes to the national classification for cannabis scheduling has occurred has been much anticipated. But what does it mean? What is scheduling? Scheduling is a national classification system that controls how…
Please complete the form on the PharmOut contact us page. We will get back to you within one business day.
Phone: +61 3 9887 6412
Email: info@pharmout.net
